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Abstract: RNAi is considered a major antiviral defense mechanism in insects, but its relative
importance as compared to other antiviral pathways has not been evaluated comprehensively.
Here, it is attempted to give an overview of the antiviral defense mechanisms in Drosophila that
involve both RNAi and non-RNAi. While RNAi is considered important in most viral infections,
many other pathways can exist that confer antiviral resistance. It is noted that very few direct
recognition mechanisms of virus infections have been identified in Drosophila and that the activation of
immune pathways may be accomplished indirectly through cell damage incurred by viral replication.
In several cases, protection against viral infection can be obtained in RNAi mutants by non-RNAi
mechanisms, confirming the variability of the RNAi defense mechanism according to the type of
infection and the physiological status of the host. This analysis is aimed at more systematically
investigating the relative contribution of RNAi in the antiviral response and more specifically, to ask
whether RNAi efficiency is affected when other defense mechanisms predominate. While Drosophila
can function as a useful model, this issue may be more critical for economically important insects that
are either controlled (agricultural pests and vectors of diseases) or protected from parasite infection
(beneficial insects as bees) by RNAi products.
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1. Introduction
RNA interference (RNAi) is considered an ancient gene silencing pathway linked to antiviral
defense [1]. Small RNA-guided antiviral immunity was first demonstrated in plants [2] and
subsequently in Drosophila [3] and Caenorhabditis elegans [4].
In Drosophila, the major RNAi pathway involved in antiviral immunity is initiated by the
processing of virus-derived dsRNA molecules to viral small interfering RNAs (viral siRNAs or
vsiRNAs) by Dicer-2 (Dcr-2) enzyme. Viral siRNAs are subsequently loaded in an effector complex
named RISC (RNAi-induced silencing complex) with Argonaute-2 (Ago-2) as central molecule.
SiRNA-programmed RISC complexes subsequently scan cellular RNA populations for complementary
sequences and cause specific RNA degradation after specific siRNA-mRNA hybridization [5].
The central factors of the siRNA pathway, Dcr-2 and Ago-2, were demonstrated to have undergone
accelerated evolution as a consequence of adaptive virus-host arms races [6]. The other RNAi pathways
in insects, characterized by microRNAs (miRNAs) and Piwi-associated RNAs (piRNAs), have recently
also been shown to be involved in antiviral defense [7]. However, the siRNA pathway is considered
the major antiviral RNAi pathway in insects [8].
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While the piRNA pathway is restricted to germline tissues [9,10], in somatic tissues the
miRNA (characterized by Dcr-1/Ago-1) and siRNA pathways (characterized by Dcr-2/Ago-2)
are maintained independently. In contrast to miRNA-dependent Ago-1-RISC, the efficient
assembly of siRNA-dependent Ago-2-RISC requires the RISC-loading complex, consisting of Dcr-2,
the dsRNA-binding protein R2D2 and TATA-binding protein-associated factor 11 (TAF11), an
unannotated basal transcription factor [11]. Reconstitution of Ago-2-RISC assembly in vitro further
shows the requirement of the chaperone machinery (Hsc70-4, Hsp83, Hop, Droj2, p23; dependent
on ATP) which is viewed to occur in analogous fashion to steroid hormone receptor maturation
(and with siRNA duplexes as ligands) [12]. Maturation of the pre-RISC complex or RISC activation
occurs after cleavage of one of the strands of the siRNA duplex by slicer activity of Ago-2 and
the endonuclease C3PO [13]. Separation of miRNA and siRNA pathways is further evident by
the localization of their components in different subcellular membrane-less organelles (P-bodies or
GW-bodies for Ago-1-RISC [14]; D2-bodies for Ago-2-RISC [15]). The separation of the miRNA from the
siRNA machinery in the cellular cytoplasm may be driven by the necessity to avoid interference in the
managing of disparate RNAi functions (maintenance of cellular gene networks versus innate immunity).
Homozygous mutants for dcr-2 and ago-2 are viable and fertile, indicating that these core siRNA
components are not required for viability and development [16,17]. Mutants for r2d2 that survive
to adulthood also show normal morphology and behavior but were found to have reduced female
fertility by a mechanism that does not involve its function in the siRNA pathway [18]. On the other
hand, over-expression of Dcr-2 was reported to increase gene silencing by RNA hairpins in transgenic
flies [19]. Other studies implicate a link between nutrient conditions and robustness of the RNAi
response. When energy levels are low and insulin/insulin-like growth factor signaling is reduced,
the forkhead transcription factor dFOXO responds by translocation to the nucleus resulting in increased
target gene expression [20]. It was observed that the induction of dFOXO in transgenic flies results in
increased expression of the RNAi machinery genes ago-1, ago-2 and dcr-2 and concomitant resistance to
virus infection [21]. In dFOXO null flies the greater susceptibility to RNA viruses can be rescued by
over-expression of Dcr-2. The increase in RNAi efficiency in cultured cells after serum starvation may
occur through a similar mechanism [22]. These data indicate that the efficiency of RNAi-mediated
silencing is not constant and linked to cellular physiology and homeostasis.
Besides RNAi, many other innate immune pathways have been proposed to be involved in
antiviral defense such as the Toll and Imd pathways, originally identified for their involvement in
antibacterial and antifungal defense, the JAK/STAT pathway, translational inhibition, transcriptional
pausing, autophagy, heat-shock response, apoptosis, phagocytosis of infected cells and phenoloxidase
activity (see references [23–31] for examples from different insect species) [23–31]. Sloughing off
infected gut cells has also been reported to clear infections of baculovirus [32]. Very recently, a detailed
review was also published that discusses the sources of variation in resistance to virus infection in
dipteran insects [33]. An interesting question relates to the relative importance of each of the proposed
innate immune response pathways to control viral infections. Research to answer this question has
already revealed that the specific antiviral response is both insect host- and virus-dependent [34,35].
Control mechanisms may differ between pathogenic and persistent infections. Virulent pathogenic
infections may be initially controlled by the host but ultimately will prevail as the virus provides a
powerful machinery for viral replication and innate immune suppression. During persistent infections,
on the other hand, a state of equilibrium seems to be established between viral maintenance and immune
surveillance. Persistent infections present interesting cases because of their long-term interactions with
the host, which could change its physiology, including immune pathways such as RNAi.
The relative importance of the RNAi pathway to control viral infections may be relevant for the
use of RNAi to achieve gene silencing in reverse genetics experiments or in the application of RNAi
for pest control. It can be assumed that viruses may evade different types of immune response in
a differential manner, with some viruses evading primarily RNAi and some viruses mainly other
defense pathways. If a virus escapes control by the RNAi pathway, other defense pathways will evolve
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to control the virus, which could lead to a temporal decrease in the efficiency of the antiviral RNAi
machinery. An interesting research avenue would be to investigate whether the relative importance
of RNAi to control viral infections may indicate its relative robustness to support endogenous gene
silencing efforts. Here, we review the variability of the immune response against viral infections in the
model insect Drosophila melanogaster, in order to show that many other antiviral strategies can exist
besides RNAi. When a multitude of responses exist, it is possible that particular non-RNAi responses
can dominate at the expense of the contribution of RNAi. Such evolution of antiviral immune response
mechanisms, which so far have not been investigated directly, may have implications for practical
applications of RNAi in insects, such as RNAi-based gene silencing experiments, control of pest insects
in agriculture and medicine, and increasing the health of beneficial insects such as bees.
2. Paradigm: RNAi as Antiviral Defense Mechanism in Drosophila
2.1. RNA Viruses
Because of its extensive genetic resources, the fruitfly D. melanogaster was used as a model to
investigate the involvement of the RNAi pathway in antiviral defense. Three major criteria are applied
to indicate the interaction between virus infection and RNAi: (1) the production of viral siRNAs
(vsiRNAs; typically, 21 nt in Drosophila) characteristic of processing by Dicer; (2) increased viral
replication and mortality in dcr-2 and ago-2 mutants; (3) the existence of viral suppressors of RNAi
(VSRs) in viral genomes (reviews by [36,37]).
The production of abundant 21 nt vsiRNAs during infection has been documented in Drosophila
tissues as well as the Drosophila-derived Schneider-2 (S2) cell line for many viruses with a positive
strand ssRNA genome (e.g., Flock house virus (FHV) and other nodaviruses, the dicistroviruses
Drosophila C virus (DCV) and Cricket paralysis virus (CrPV), Nora virus (Picornavirales)) and several
viruses with a dsRNA genome (e.g., Drosophila X virus (DXV, Birnaviridae)) (reviews by [7,8,27,36]).
In S2 cells, approximately equal numbers of vsiRNAs were derived from genomic and antigenomic
strands, implicating an origin from replication intermediates or complete genomes in the case of
dsRNA viruses [38]. The vsiRNAs that are produced are functional since they inhibit reporter gene
activity in appropriately designed sensor assays (constructs that connect the luciferase ORF with
sequences of the viral genome [39]). Interestingly, even when vsiRNAs accumulate at much lower
levels, such as in loqs mutants, viral infection can be controlled efficiently, indicating the efficiency of
RNAi antiviral immunity can be relatively insensitive to the abundance of vsiRNAs [40]. As expected,
flies that were mutant for dcr-2, ago-2 or r2d2 were more susceptible to RNA virus infection, manifested
by increased mortality and higher virus titers [5,34,41].
In all the above-mentioned RNA viruses (FHV, DCV, CrPV, Nora virus, DXV), VSRs were
identified, that can block the RNAi mechanism either at sensor or effector levels. The B2 protein
of FHV binds both dsRNA and siRNA with high affinity, protecting it from Dicer activity [42];
in addition, the C-terminus of B2 can interact with Dicer-2 to prevent the loading of RISC with
siRNA [43,44]. For dicistroviruses, the N-terminal 99 amino-acids of DCV (DCV-1A protein) acts as
a VSR through binding of dsRNA and to a lesser extent siRNA by its dsRNA-binding motif, while
the N-terminal CrPV-1A protein (148 amino-acids) binds Ago-2 and interferes with the function of
holo-RISC [5]. Similar to CrPV-1A, the VSR of Nora virus, VP1, inhibited slicer activity of pre-loaded
RISC in cellular and embryonal extracts [45]. Interestingly, Nora virus of Drosophila immigrans was
only capable to inhibit slicer activity in D. immigrans extracts and not in D. melanogaster extracts and
to interact with conspecific Ago-2, indicating host-specific evolution of the VSR protein [39]. Finally,
the VP3 protein of entomobirnaviruses such as DXV and Culex Y virus, characterized by two linear
dsRNA genome fragments, represents a multifunctional protein that also interacts with dsRNA to
form ribonucleoprotein complexes, as such simultaneously acting as a VSR [46,47].
It was also observed that RNA virus infection or ectopic expression of VSRs can inhibit
dsRNA-mediated silencing of cellular or reporter genes (e.g., DCV and CrPV [5,41]; DXV [47]), although
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this may depend on the viral infection levels and achieved VSR expression levels. VSR activity has
also been demonstrated to interfere with the endo-siRNA pathway (which controls expression of
transposable elements [5]), while the miRNA pathway remains largely unaffected during viral infection in
insects [5,41,45]. The latter situation contrasts with RNA virus infection in plants where interference with
miRNAs can lead to physiological and developmental defects, which contribute to viral disease [48,49].
2.2. Arbovirus Infections in Drosophila
Flies and Drosophila-derived cell lines have been extensively used as models to study infections
of arboviruses that naturally are vectored by mosquitoes [29]. Those studies do not only include
infections with RNA viruses with positive-strand ssRNA genome (e.g., Sindbis virus and Semliki
Forest virus (SINV and SFV; both Alphavirus, Togaviridae)), but also with negative-strand ssRNA genome
(e.g., Vesicular stomatitis virus (VSV; Rhabdoviridae)) and segmented negative-strand/ambisense ssRNA
genome (e.g., Rift Valley Fever virus (RVFV; Bunyaviridae)) (reviews by [7,8,27,36].
While arbovirus infections can cause severe disease in mammalians, arboviruses cause no or
only mild pathogenic effects in mosquito vectors. Such non-pathogenic, persistent state of infection
by arboviruses occurs also in mosquito- and Drosophila-derived cell lines [50]. As for the other RNA
viruses, infections with arboviruses also result in the production of 21 nt vsiRNAs, indicative of
processing by Dicer-2. For alphaviruses (SINV and SFV), vsiRNAs were equally distributed between
genomic and antigenomic strands and therefore likely originate from replication intermediates with
dsRNA structure [51,52]. Also, VSV infections produce 21 nt vsiRNAs that are approximately evenly
distributed between genomic and antigenomic strand [51,53]. Sensor assays established that vsiRNAs
from VSV infections can efficiently knock down engineered reporter constructs, indicating their loading
in functional RISC complexes [53]. On the other hand, it was also observed that defective interfering
(DI) particles can be produced during VSV infections. DI particles correspond to a 1.6 kb region at the
5′-end of the VSV genome and are the source of abundant vsiRNAs [51]. Interestingly, knockdown
of ago-2 results in a decrease in vsiRNAs outside the 1.6 kb region, while an increase is observed
within the 1.6 kb region. Because Ago-2 stabilizes siRNAs, this result is interpreted that the abundant
vsiRNAs, likely derived from DI particles, are not loaded in Ago-2 and therefore non-functional [54].
Finally, RVFV 21 nt vsiRNAs, isolated after infection of Drosophila cells, distribute more or less equally
between positive and negative RNA strands for the M and L segments. In the S segment, a large
fraction of the vsiRNAs map to a particular region in the antigenome that resembles a stem-loop [54].
Drosophila flies mutant for dcr-2 and r2d2 (but not loqs, involved in the miRNA pathway) showed
increased levels of SINV genomes and for r2d2 mutants also a decrease in lifespan was observed [51].
VSV infections also resulted in increased mortality in dcr-2, r2d2 and ago-2 mutant flies that could be
correlated with a large increase in viral titers [53,54].
Given their propensity to establish persistent infections, it is under debate whether arboviruses
encode VSR proteins. For instance, when the alphavirus SINV is engineered to express a heterologous
VSR, such as VP1 from Nora virus, increased mortality is observed after injection in wild-type flies [45].
By contrast, no differences in mortality are observed between control SINV and SINV-VP1 in dcr-2
mutants, indicating that the increased pathogenicity of SINV-VP1 results from suppression of the
RNAi mechanism. In the case of SINV, the absence of a VSR gene in its genome therefore clearly
correlates with its propensity to establish persistent infections that do not cause pathogenic effects.
However, for other arboviruses, such as flaviviruses, strong evidence exists that they encode a VSR
protein. Using the same experimental approach as discussed above, it was demonstrated that the
capsid protein of West Nile virus and other flaviviruses could function as a VSR in the context of
infections of mosquitoes with recombinant SINV [55].
2.3. DNA Viruses
Invertebrate iridescent virus 6 (IIV-6; Iridoviridae), a complex virus with a large dsDNA genome of
>200 kb encompassing >200 ORFs, was used as a model for DNA virus infections in Drosophila [36,56].
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While the virus is not specific to Drosophila, it has a broad host range and can cause pathogenic
infections in flies.
During infection of flies with IIV-6, 21 nt vsiRNAs are produced that are produced from hot spots
on the viral genome [56]. Further analysis indicated that vsiRNAs are derived from overlapping sense
and antisense transcripts (forming dsRNA structures) rather than from strong stem-loop structures in
single-stranded mRNAs. Sensor assays indicated that the vsiRNAs produced during IIV-6 infection
were fully functional for RNAi.
IIV-6 infection of dcr-2, r2d2 or ago-2 mutant flies resulted in higher mortality [34], which, however,
was accompanied with only a modest increase in viral titers [56]. Furthermore, ORF340R protein,
which contains a canonical dsRNA-binding domain (dsRBD), was identified as a VSR [36]. ORF340R
binds both dsRNA and siRNA and therefore impairs both processing by Dicer-2 and RISC assembly.
VSR activity is rather strong since dsRNA-mediated silencing of a reporter gene is inhibited during
IIV-6 infections [36]. On the other hand, the absence of a 22 nt peak during infections of dcr-2 mutant
flies suggests that no viral miRNAs are produced by IIV-6 [56].
Vaccinia virus (VACV) is a mammalian cytoplasmic DNA virus (Poxviridae) that also has a complex
dsDNA genome of 200 kb. During infection of Drosophila cells, it cannot undergo a complete replication
cycle; nevertheless 21 nt vsiRNAs are produced that are dependent on Dicer-2 [54]. The genomic
termini of VACV that contain 30 tandem repeats of a 70 nt element with hairpin structure, were
identified as the source of the most abundant vsiRNAs. Interestingly, VACV infection of Drosophila
cells also leads to addition of non-templated adenosines at the 3′-end of (Ago-1-loaded) miRNAs that
causes their degradation [57]. This phenomenon was also observed during infection of lepidopteran
cells derived from the tiger moth Amsacta moorei during entomopoxvirus infection and may have
evolved as an additional antiviral mechanism [57].
2.4. No Involvement of the piRNA Pathway in Antiviral Defense
In contrast to mosquitoes [58], there is no convincing evidence that the piRNA pathway is
involved in antiviral defense in Drosophila. In Drosophila, expression of the main components of the
piRNA pathway is restricted to the gonads, where it is involved in the silencing of transposable
elements [9,10]. Ovarian tissue can be divided in two cell types, germline cells (oocyte and nurse
cells) and somatic support cells, which differ with respect to the piRNA “module” that is expressed.
Somatic support cells and the derived ovary somatic sheet (OSS) cell line, express the “linear” piRNA
module, in which primary piRNAs are loaded in nuclear Piwi to mediate transcriptional silencing
of transposons. Germline cells, on the other hand, are characterized by an efficient mechanism of
posttranscriptional silencing in the cytoplasm through the abundant production of secondary piRNAs
by a “ping-pong” amplification mechanism executed by the Piwi-class Argonaute proteins Aubergine
(Aub) and Ago-3 [59]. Small RNA deep sequencing established that OSS cells are persistently infected
with RNA viruses, including DCV, DXV, Nora virus and American Nodavirus (ANV; closely related to
FHV), and that 21 nt vsiRNAs can be readily detected [38]. Interestingly, a second class of 24–30 nt
viral small RNAs is also present that exhibits a strong bias both for sense polarity (genomic strand for
DCV, Nora virus and ANV, and mRNA for DXV) and for uridine at the 5′-end, a hallmark for piRNAs.
The viral piRNAs (vpiRNAs) are produced by the “linear” (primary) piRNA pathway, as expected for
the OSS cell line, while no evidence was found for the “ping-pong” amplification mechanism [38].
By contrast, a comprehensive study, which investigated viral infections in piRNA mutant flies
(Piwi, Aub, Ago-3 and Zucchini (Zuc)), did not observe any increase in virus accumulation or mortality
compared with wild-type flies [60]. No clear evidence for production of vpiRNAs was found, even
in dcr-2 and ago-2 mutants, thus ruling out a possible compensating role for the piRNA pathway
in the absence of the siRNA pathway [60]. No differences were observed between wild-type and
piRNA mutant flies during acute or persistent infections, infections with RNA or DNA viruses, or
infections with viruses that are naturally vertically transmitted such as Sigma virus (Rhabdoviridae),
and therefore replicate in the gonads. In the study, care was taken to isogenize all fly piRNA mutant
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lines before experimental manipulation to minimize effects of different genetic background that could
have affected the results of earlier studies, wherein a higher susceptibility of piwi or aub mutant flies
to viral infections were reported [61,62]. The observation of vpiRNAs may, therefore, be a peculiar
feature of the OSS cell line that differs from the situation in adult flies.
2.5. DNA Viruses and Their Interaction with the miRNA Pathway
Interaction with the miRNA pathway has been mostly documented for large DNA viruses, such as
baculovirus [63], while its role during RNA virus infections is less clear [64,65]. Because virus research
in Drosophila has focused on RNA viruses, reports on interactions with host miRNAs or production of
viral miRNAs are scarce. An interaction with the miRNA pathway was described during infections of
Drosophila cells with the mammalian Vaccinia virus (VACV; Poxviridae) [57]. Deep sequencing of viral
small RNAs also detected an abundant miRNA that is produced during infection with Kallithea virus,
a large DNA virus (Nudiviridae) [39]. Extension of research on antiviral immunity to DNA viruses is
therefore expected to highlight the importance of the miRNA pathway.
2.6. RNAi in Combination with Other Degradation Pathways
Next generation sequencing indicates that virus infections generate unique patterns of viral small
RNAs, defined by the abundance of reads for each size between 15 and 35 nt [66,67]. The diversity of
viral small RNA patterns is consistent with the diverse origins of small RNAs that are generated by the
siRNA pathway (21 nt vsiRNAs), the piRNA pathway (27–28 nt vpiRNAs; not important in Drosophila
but prominent in mosquitoes) and non-specific RNA degradation pathways (no size enrichment but
biased towards the viral genomic strand). Virus-specific small RNA patterns are the result of the
interaction between divergent strategies of viral replication with host-specific antiviral responses and
have been used for virus classification and identification of new virus species [66]. The possible role of
RNA degradation pathways that are different from RNAi will be discussed further below (Section 3.2).
2.7. Systemic Antiviral RNAi-Based Immunity
RNAi is considered cell-autonomous in insects, including Drosophila, which means that the
silencing process is limited to the cells in which the dsRNA is introduced or expressed [68].
In transgenic Drosophila, silencing effects that result from RNA hairpin transgenes are strictly restricted
to the expressing cells and do not extend to neighboring cells [69]. The absence of robust systemic effects
was attributed to the absence of an RNAi amplification mechanism (RNA-dependent RNA polymerase
homolog) in insects and a dsRNA transport mechanism (SID-1 dsRNA transporter homolog) in
dipterans [70].
However, addition of dsRNA to the cell culture medium or through injection in flies demonstrated
systemic silencing effects, indicating the existence of a functional dsRNA uptake pathway [22,71].
In S2 cells, functional RNAi-based screens identified receptor-mediated endocytosis as the major
pathway for gene-silencing through “dsRNA soaking”, i.e., in the absence of transfection agent [72,73].
The screens identified genes involved in the endocytotic pathway, the oligomeric Golgi complex,
cytoskeleton organization, protein transport, lipid metabolism and modification, and with unknown
function [72]. In addition, the scavenger receptors SR-CI and Eater were identified as the membrane
proteins to interact with exogenous dsRNA and mediate its internalization [73]. Interestingly, SR-CI
and Eater are preferentially expressed in macrophage-like hemocytes, which agrees with the observed
more efficient silencing in this cell type following dsRNA injection [71].
These studies were subsequently extended to adult flies where genes involved in dsRNA uptake
in S2 cells, such as egghead, CG4572 and ninaC, were shown to be required for antiviral defense against
DCV and SINV infections [74]. It was therefore hypothesized that dsRNA released by lysed cells
during infection could be taken up by other cells and initiate a systemic antiviral response in the whole
organism [75]
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The latest studies however confirm a pivotal role for hemocytes in RNAi-mediated antiviral
defense that is both systemic and adaptive [76] (for a more extensive discussion on the role of hemocytes
in non-RNAi aspects of antiviral immunity, see also Section 3.8). Hemocytes are not efficiently infected
with SINV, but are proposed to acquire viral dsRNA through phagocytosis of dying cells from other
tissues [30] or direct endocytosis from the hemolymph. Uptake of dsRNA in combination with viral
infection subsequently initiates an amplification mechanism in the hemocytes that comprises the
generation of viral DNA forms (after reverse transcription by endogenous retrotransposons; [77]) that
function as templates for the production of secondary viral siRNAs as an amplification mechanism [78].
Secondary viral siRNAs provide systemic protection after their secretion in exosomal-like vesicles that
are formed from multivesicular bodies. Exosomes generally are implicated in cell-cell communication
and transmission of disease states, i.e., through the transfer of small RNAs [79]. In this model,
the production of viral DNA forms provides a type of immune “priming” (or memory) that confers
protection against future infections of the same (but not other) viruses [76]. In addition, exosomal-like
vesicles can provide passive immunity since their transfer from infected flies will protect non-infected
flies from viral infection.
The notion of “immune priming” may be a variable process and dependent on the type of virus
since it was not observed in other studies [80]. In addition, other mechanisms for a systemic antiviral
RNAi-based system were proposed, based on nanotube-like structures [81].
2.8. RNAi in Persistent Virus Infections
Viruses are usually associated with causing disease, but deep sequencing efforts have revealed
the existence of many “persistent” virus infections in insects, including Drosophila [67], that occur
without obvious fitness costs to the host. In persistent infections, host and virus use attack and
counter-attack until equilibrium is reached where viral replication is controlled but not eliminated [77].
The establishment of persistent infections therefore is dependent on two major factors: (1) repression
of viral replication such that pathogenic effects are avoided, and (2) the evasion or suppression of the
immune response [82–84].
The classic example of persistent infection is the arbovirus infection of mosquitoes, in which viral
replication is suppressed by the RNAi machinery to such levels that pathogenicity is avoided [50].
If arboviruses are engineered to express an RNAi inhibitor, persistent infections are transformed into
pathogenic infections that cause mortality to the mosquito hosts [45]. Most research on the mechanism
of viral persistence in Drosophila, however, is based on infections of cell lines with the model virus FHV
(Nodaviridae) that encodes a well-characterized RNAi inhibitor (Section 2.1; [42,43]. When Drosophila
culture cells are acutely infected with FHV, extensive lysis and mortality is observed. However,
a small proportion of cells survives and establishes a persistent infection that is characterized by low
level replication and absence of cytopathic effects [85]. Nevertheless, the virions produced by the
cells retain their full infectivity as they were shown to cause mortality in flies with the same rate as
virions produced during acute (pathogenic) infections [77]. This observation indicates that the state
of persistence occurs at the level of the physiology of the cells rather than through changes in the
viruses themselves.
The mechanism of persistence of FHV in Drosophila cell lines seems to involve several factors. One
mechanism that was proposed most recently was the establishment of an amplification of the RNAi
response through the formation of viral DNA forms. In this mechanism, FHV viral RNA is reverse
transcribed in conjunction with endogenous retrotransposons to DNA, which is maintained stably in
the cells and functions as a continuous source of viral dsRNA/siRNAs that control the infection [77].
The generation of viral DNA forms was also demonstrated for infections of other RNA viruses such as
DCV, DXV and SINV.
Staining of viral proteins however showed the different “character” of persistent infection as a
different intracellular distribution was observed between persistent and lytic infections [86]. The altered
subcellular distribution may represent a suboptimal environment for replication and virion formation
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during persistence. The distribution pattern of viral siRNAs along the viral genome during persistent
infection resembles the pattern observed during acute infections with FHV that has a deletion of the
B2 protein [40,87], indicating increased susceptibility to the RNAi machinery.
Another contributing factor may be the production of defective interfering (DI) RNAs that
continue replicating in the presence of viral RNA polymerase and preferentially may accumulate
during persistent infections. DI RNAs interfere with the infection process through dampening of viral
replication and mis-incorporation into viral capsids [86,88]. Furthermore, DI RNAs can be a source of
both abundant small RNAs with the potential to target genomic viral RNAs for degradation as well as
truncated proteins with inhibitory effects on the infection process.
Besides RNAi, other mechanisms play a role to establish persistent infections. It was shown
that activation of the phosphatidylinositol-3-kinase-Akt pathway, which is associated with growth
factor signaling and plays an important role in cell proliferation and survival, can increase infections
of SINV [89]. Replication of SINV was dependent on the levels of Akt expressed in the cells and,
reciprocally, SINV infection resulted in increased phosphorylation of Akt and its target glycogen
synthase kinase β. Through the increased expression of the cap-binding complex, the infected cells can
accommodate translation of capped viral mRNAs without significant disruption of cellular function
which is essential for the persistence of the infection.
3. Innate Antiviral Immunity beyond RNAi
While RNAi is generally recognized as a major antiviral pathway in Drosophila, it has equally
been realized that many other defense mechanisms exist [27,28]. The question can then be raised
regarding the relative importance of RNAi versus other defense pathways. More specifically, it can be
asked whether such alternative defense mechanisms could provide protection against viral infection
in the absence of the RNAi. In addition, disablement of antiviral RNAi defenses can provide the basis
for susceptibility to virus infections, as documented for infections of C. elegans by Orsay virus [90].
The possible existence of insects with a deficient antiviral RNAi pathway can also have practical
importance from the point of view that RNAi is also developed as a new method for pest control [91,92].
In the next sections, an overview is presented of the “non-RNAi” antiviral defense mechanisms in
Drosophila and if evidence exists whether viral infections can be controlled in the absence of RNAi.
3.1. Mutations in Drosophila Populations that Confer Resistance against Natural Viral Pathogens
Genome-wide association studies have revealed polymorphisms that have major effects on
resistance against viruses that naturally infect Drosophila, but not against other viruses [93,94]. Through
long-term evolution with natural infections, viral resistance can emerge either by changing the immune
system (at the level of “antiviral genes”) or by altering host factors that are used by the virus during its
replication cycle (at the level of “proviral genes”) [95].
The studies focused on two natural viral pathogens of D. melanogaster. D. melanogaster Sigma virus
(DMelSV; Rhabdoviridae) is a host-specific pathogen that is only transmitted vertically through sperm
of egg. Infection by DMelSV is considered benign although reduced fitness can be observed. DCV
(Dicistroviridae), of which the interaction with the RNAi machinery has been investigated extensively
(see above), on the other hand, can infect a range of Drosophila species through feeding. Oral infection
of DCV in adult flies can cause 25% lethality after a period of 20 days [96].
Three major loci are associated with resistance against DMelSV. First, a transposon insertion and
further arrangements at ref(3)D are associated with increasing levels of resistance against DMelSV [97].
Interestingly, mutations in the locus also increase resistance to organophosphate insecticides [98]
and the genes affected (CHKov1 and CHKov2) are characterized by a choline kinase domain, possibly
linking the resistance mechanism to the level of viral entry since the acetylcholinesterase receptor
can function as a cellular receptor for other rhabdoviruses [99]. The second gene is known as ref(2)P
or p62 and encodes an adaptor protein of which one of the functions is the selective targeting of
polyubiquitinated protein substrates for degradation by autophagy [93,100]. The involvement of p62 in
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DMelSV defense could therefore occur through its role in autophagy, a process that is known to protect
against other rhabdovirus infections [101] (see also Sections 3.2.2 and 3.8). Interestingly, ref(2)P/p62
also forms a complex with atypical protein kinase, which stimulates the innate immune Toll signaling
pathway and the induction of antimicrobial peptides (AMPs) [102,103] (see also Section 3.3). The third
gene, ref(2)M, encodes Ge-1 that plays a role in processing of RNA and the formation of P-bodies
or GW-bodies [93,104]. While Ago-2 is also a component of P-bodies [105] and ago-2 mutants show
increased titers of DMelSV, no genetic interaction was found between ago-2 and Ge-1 [93]. On the other
hand, Ge-1 is known to interact with Decapping protein 1 (Dcp1), an enzyme that removes the 5′-caps
from mRNAs and also localizes to P-bodies. Furthermore, knocking down of Dcp1 also results in
higher titers of DMelSV. Thus, the resistance mechanism by Ge-1 is hypothesized to be at the level of
degradation of viral genomic RNAs or mRNAs in P-bodies in an RNAi-independent manner ([93];
see also Section 3.2.4).
On the other hand, a single gene, pastrel, is the dominant factor that regulates susceptibility
to DCV infections [95,106]. In this case, resistance is achieved through higher expression levels of
pastrel, independent of which allele was used. However, while pastrel was reported to participate in
protein secretion and also associates with lipid droplets, the molecular mechanism in viral resistance
remains unknown.
The identified resistance genes act very specifically against DMelSV and DCV infections. Genes
that affect DMelSV resistance have no effect on the infectivity of the closely related D. affinis Sigma
virus (DAffSV) as well as of DCV, FHV or Drosophila A virus (DAV; related to Permutotetraviridae);
in addition, pastrel mutations do not influence FHV, DAffSV and DMelSV infections [95,106].
On the other hand, when a Drosophila population was experimentally selected for resistance
against DCV infection, the evolution of resistance to DCV also led to partial protection against CrPV
and FHV infections [107]. Protection was strong against CrPV (a dicistrovirus closely related to DCV)
but only moderate against FHV while no significant increase in resistance was found against bacterial
infections. Mapping of the resistance alleles revealed that adaptation to DCV and cross-resistance
to other viruses relies on a few major genes. The most significantly differentiated genetic change
mapped to the pastrel gene (also identified in genome-wide association studies mentioned above)
which was associated with increased protection against the dicistroviruses CrPV and DCV but not
against the nodavirus FHV [107]. Two other genetic changes were located in the gene Ubc-E2H
(encoding Ubiquitin-conjugating enzyme E2H) which was also associated with specific protection
against dicistrovirus infection. By contrast, RNAi knockdown identified CG8492 (encoding lysozyme)
with decreased survival to DCV and FHV but not to CrPV. It is noted that the variation in virus resistance
is based on genes that are unrelated to the canonical antiviral defense pathways such as RNAi.
3.2. Identification of Host Factors that Restrict Viral Infection by RNAi Screens in Cultured Cell Lines
Following up on the observation that the addition of long dsRNAs to the medium of Drosophila
culture cells results in specific gene knockdown, this cell culture system was adapted to perform
large scale RNAi screening assays to identify genes involved in particular cellular processes [108,109].
This approach was also used to identify host factors that either facilitate or restrict virus infection
(viral sensitivity factors (VSFs) or viral resistance factors (VRFs), respectively [110]). Because of
their importance to human health, emphasis was placed on arboviruses that are transmitted by
mosquitoes but also can establish persistent infections in Drosophila cell lines and adult flies, such as
SINV (Alphaviridae), RVFV and La Crosse virus (LACV) (Bunyaviridae), Dengue virus (DENV) and
different strains of West Nile virus (WNV), such as the Kunjin strain (KUN) (Flaviviridae) and VSV
(Rhabdoviridae) [111]. The Drosophila-specific pathogen DCV was also often included in the screens
because it could serve as a model for pathogenic enterovirus infections in mammals [112], while other
Drosophila- (Nora virus) or insect-specific viruses (FHV) were rarely included. Besides genome-wide
screens, also targeted screens were performed, for instance targeting specific signaling pathways,
Viruses 2018, 10, 230 10 of 35
immune genes, RNA helicases, RNA metabolism and endoplasmic reticulum (ER)-associated
proteins [101,113–116].
Because the RNAi technology has major limitations associated with weak silencing and off-target
effects [111], considerable efforts were undertaken to validate candidates of important host factors,
by gene silencing and mutant analysis in adult flies and confirmation of results in mosquito
cells [110,113,117–119]. Furthermore, it was regularly observed that host factors in Drosophila cells
were conserved in mammalian (human) cells [114–116,119–122]. The results of the screens with respect
to the (validated) identification of both new resistance mechanisms (VRFs, “antiviral genes”) as well
as (often virus-specific) cellular processes that are limiting to viral infection (VSFs, “proviral genes”)
are summarized in Table 1. Below follows a more detailed discussion of the major themes that have
emerged from the large-scale RNAi screens for VSFs and VRFs.
3.2.1. No Identification of RNAi Machinery Components
Although considered a major antiviral pathway, it is striking that no core RNAi factors (Dcr-2,
Ago-2) were discovered in the genome-wide RNAi screens. This could partially be explained by the
set-up of the assay that prevents the complete knockdown of genes that are necessary for the silencing
process. Nevertheless, targeted “RNAi-of-the-RNAi” screens have been performed successfully to
identify core and associated RNAi factors in cultured cell lines [72,73,123].
While some antiviral factors were found to be associated with the RNAi machinery, no clear
evidence was found that their antiviral action was (mainly) mediated through the RNAi process. While
loss of Ars2 leads both to a decrease in siRNA-mediated silencing and an increase in viral infection,
functions of Ars2 were also uncovered in miRNA-mediated silencing (which is not considered a
canonical antiviral pathway in Drosophila) [124]. Ars2 also interacts with components of the nuclear
cap-binding complex in addition to Pasha (co-factor of Drosha, miRNA pathway) and Dcr-2. The role
of Ars2 in antiviral defense therefore could be much more complex than just by acting as a cofactor in
Dcr-2 processing.
The DEAD box RNA helicase Rm62 was identified as an antiviral factor of RVFV infection in the RNAi
screens [114]. In another study, Rm62 was also shown to bind Ago-2 and control siRNA silencing [61].
However, studies in mammalian cells indicate that DDX17, the homolog of Rm62, can interact with the
intergenic region of RVFV that resembles a miRNA hairpin [113]. Since DDX17 also interacts with enzymes
in the canonical mRNA degradation machinery, it was proposed that Rm62/DDX17 may function as an
RNA sensor of RVFV infection to facilitate (RNAi-independent) degradation [114].
Finally, an ancient antiviral role was demonstrated for Drosha, the RNase III component of the
microprocessor complex that processes primary miRNA transcripts in the nucleus [122]. However,
Drosha is proposed to act as an antiviral factor through direct recognition/processing of RNA stem
loops, conform to its ancestral function, independently of the antiviral RNAi machinery (Dcr-2, Ago-2)
or its role in primary miRNA processing, that both later evolved.
3.2.2. Virus-Specific VRFs (Antiviral Genes) and VSFs (Proviral Genes)
Factors that specifically restrict bunyavirus (RVFV, LACV) infections include three genes (Dcp2,
LSM7, Me31B; Table 1) that are involved in the process of de-capping of host mRNAs [125].
The de-capping process plays an important role in the bunyaviral infection cycle since 5′-caps for
bunyaviral mRNAs are acquired by “cap-snatching” the 5′-ends of cellular mRNAs. Viruses that
do not “cap-snatch” the 5′-end of host mRNAs, such as VSV, DCV and SINV, were not affected by
the knockdown of the de-capping factors. Interestingly, sensitivity to knockdown of cell cycle genes
(Table 1) was explained by the preferential cap-snatching from cell cycle mRNAs [125].
Genome-wide RNAi screens resulted in the identification of the cellular receptor required for
SINV infection, i.e., Malvolio (Mvl) or divalent metal ion transporter natural resistance-associated
macrophage protein (dNRAMP) (Table 1; [117]). Further studies demonstrated that expression of
dNRAMP is regulated by genes in the ER-associated protein degradation (ERAD) pathway (dSEC61A,
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dVCP) and the proteasome (dPSMD11) (Table 1; [119]). On the other hand, dNRAMP was completely
dispensable for WNV and VSV infections.
Translation of DCV dicistroviral proteins is initiated by internal ribosomal entry sites (IRES) in
the viral mRNAs. RNAi screens established that DCV replication is specifically inhibited following
knockdown of ribosomal proteins (RpS6, RpL19; Table 1). The requirement for expression of high
levels of the translation machinery was not observed for VSV which uses a 5′-cap initiated translation
mechanism [126]. Interestingly, in yeast, ribosomal protein RpS25, which is not an essential protein,
is required for interaction of the (intergenic region (IGR)) IRES from CrPV with the 40S ribosomal
subunit and subsequent translation [127].
When an RNAi screen was performed targeting 16 ribosomal proteins, previously identified
to interact with the core RNAi machinery (Dcr-2, Ago-2, R2D2), depletion of RACK1 was found to
decrease significantly the viral titers of the dicistroviruses CrPV and DCV, but not of FHV (Nodaviridae)
and VSV (Rhabdoviridae) [128]. While initially identified as an adaptor protein interacting with a variety
of signaling molecules (e.g., protein kinase C), RACK1 was later identified as a component of the 40S
ribosome subunit. Also silencing of the eIF3j subunit of the translation initiation factor eIF3 interfered
with dicistrovirus infection. Although RACK1 is also involved in miRNA function, its major inhibitory
action on dicistrovirus replication seems to be by acting as a scaffold protein to recruit signaling
pathway components to regulate translation at the (5′- but not the IGR) IRES, for instance through
modification of eIF3j [128].
Interaction with Toll-7 and its subsequent activation of autophagy was identified as an antiviral pathway
protecting against viruses with a negative strand RNA genome such as VSV and RVFV [26,101,129]. Antiviral
Toll-7 signaling was independent of the Toll signaling components MyD88 and the NF-κB transcription
factor Dif [26]. Depletion of the insulin signaling component Akt, which increases autophagy, inhibited
VSV replication [101]. The Toll-7/autophagy pathway was not involved in protection against viruses
with a positive RNA genome such as DCV, FHV and SINV [101,129].
The screening of a library of biologically active molecules identified several drugs that restrict
RVFV infection [121]. Drugs inhibiting ion pumps, the cytoskeleton and protein kinase C (PKC) as
well as apoptosis inducers were significantly overrepresented among the compounds that attenuated
viral infection. Targeted screens identified the specific requirement of the PKC epsilon isozyme (PKCε)
at an early step in the infection cycle. Silencing of PKC98e (PKCε homolog) in adult flies resulted in
increased sensitivity to RVFV infection, while no effects were observed on DCV infection [121].
When a targeted RNAi screen for silencing of genes involved in glycerophospholipid metabolism
was performed, five genes were identified that are involved in FHV RNA replication [130]. The specific
requirement for genes involved in phosphatidylcholine synthesis can be explained by the association
of the FHV replication process to the outer mitochondrial membranes and the identification of the
viral RNA-dependent RNA polymerase as a lipid-interacting protein.
Following a CRISPR screen in human cells, subsequent validation experiments by RNAi in
Drosophila cells confirmed the requirement for the signal peptidase complex for proper cleavage of
WNV and DENV structural proteins and secretion of viral particles [116]. At least in human cells,
silencing of signal peptidase complex subunits has no effect on alphavirus, bunyavirus or rhabdobvirus
infections, indicating a specific requirement for infections by flaviviruses.
Although not identified in RNAi-based screens, another antiviral mechanism can be mentioned
that is specific for FHV. FHV was demonstrated to be a cardiotropic virus in Drosophila that is controlled
by a mechanism that involves ATP-sensitive potassium (KATP) channels [131,132]. Genetic interactions
occur between potassium channel and ago-2 mutations leading to the proposition that RNAi can be
regulated by potassium ions, as is observed for other immune response mechanisms in mammals.
By contrast, modulation of activity of KATP channels did not affect infections by DCV.
DsRNA-binding proteins are another example of factors that can contribute to antiviral immunity.
Disconnected Interacting Protein 1 (DIP1) has a role in tRNA processing and maturation but has also
antiviral activity against DCV infections, in contrast to DXV infections [133].
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Table 1. Overview of genome-wide or more targeted RNAi screens to identify cellular factors that affect virus infection in Drosophila tissue culture cells. Identification
of proviral genes (encoding viral sensitivity factors) and antiviral genes (encoding viral resistance factors) is indicated. Only genes that have been validated in adult
flies are included. Abbreviations: SINV, Sindbis virus; DXV, Drosophila X virus; RVFV, Rift valley fever virus; LACV, LaCrosse virus; DCV, Drosophila C virus; DENV,
Dengue virus; KUN, Kunjin virus (strain of WNV); WNV, West Nile virus; IIV-6, Invertebrate iridiscent virus 6; FHV, Flock house virus; VSV, Vesicular stomatitis virus.
Virus Family Virus Cellular Process Genes/Factors/Complexes References
Birnaviridae DXV translation Pelo/Hbs1 complex (proviral) [135]
Bunyaviridae RVFV intracellular signaling PKC98e (PKCε homolog) (proviral) [121]
RVFV transcriptional pausing,induction of antiviral genes P-TEFb (positive elongation factor) (antiviral) [118]
RVFV induction of antiviral genes FoxK transcription factor (antiviral) [136]
RVFV, LACV cap-snatching of host mRNAs -Decapping protein 2 (Dcp2) (antiviral)-Me31B, LSM7 (decapping activators) (antiviral) [125]
RVFV, LACV cell cycle -DNA replication factor A complex (antiviral)-CycA, cdc2, RnRs (proviral) [125]
RVFV autophagy -Atg5, Atg7, Atg18 (autophagy machinery) (antiviral)-Toll-7, Traf6 (signaling pathway) (antiviral) [129]
RVFV chromatin remodeling TIP60 histone acetyltransferase complex (antiviral) [110]
RVFV nucleo-cytoplasmic shuttling XPO1 (antiviral) [110]
RVFV, LACV RNA sensor Rm62 DEAD-box helicase (antiviral) [114]
RVFV RNA degradation -3
′-to-5′ RNA exosome (dRrp6, dDis3, dRrp4, dRrp41) (antiviral)
-exosome cofactor TRAMP complex (dMtr4, dZcchc7) (antiviral) [115]
Dicistroviridae DCV translation
ribosomal proteins RpS6, RpL19 (proviral)
ribosomal protein RACK1 (proviral)
initiation factor eIF3j (proviral)
Pelo/Hbs1 complex (proviral)
[126,128,135]
DCV endocytosis Rab5 (proviral) [134]
DCV vesicular transport COPI coatamer (retrograde transport Golgi-ER) (proviral) [134]
DCV fatty acid biosynthesis SREBP, fatty acid synthase (proviral) [134]
DCV RNAi (siRNA, miRNA) Ars2, CBP20, CBP80 (antiviral) [124]
DCV transcriptional pausing,induction of antiviral genes P-TEFb (positive elongation factor) (antiviral) [118]
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Table 1. Cont.
Virus Family Virus Cellular Process Genes/Factors/Complexes References
DCV induction of antiviral genes
-Nup98 (nucleoporin with role in transcription) (antiviral)
-FoxK transcription factor (antiviral)
-B52 (virus-induced gene) (antiviral)
[136,137]
DCV intracellular signaling ERK signaling pathway(dSos, dRas, dMek, dErk (rl), ksr, cnk) (antiviral) [113]
DCV transmembrane signaling -PVR receptor tyrosine kinase (antiviral)-Pvf2 ligand of PVR (antiviral) [112]
DCV RNA degradation Drosha (RNAi independent) (antiviral) [122]
Flaviviridae DENV ER function α-glucosidase (proviral) [120]
KUN, WNV
DENV-2 ER function signal peptidase complex (SPCS1, SPCS2) (proviral) [116]
DENV vacuolar acidification V-ATPase (proviral) [120]
DENV unfolded protein response DnaJ-1, CG3061 (proviral) [120]
DENV endocytosis, vesicular transport α-adaptin, cnir, lqf, synaptogyrin, Syx4, Syx13 (proviral) [120]
DENV RNA metabolism -RNA-binding proteins: bol, Unr, CG5205 (proviral)-3′–5′ exonuclease-like CG6744 (proviral) [120]
KUN transcriptional pausing,induction of antiviral genes P-TEFb (positive elongation factor) (antiviral) [118]
KUN, WNV,
DENV chromatin remodeling TIP60 histone acetyltransferase complex (antiviral) [110]
KUN, WNV,
DENV nucleo-cytoplasmic shuttling XPO1, aldolase (antiviral) [110]
KUN induction of antiviral genes -Nup98 (nucleoporin with role in transcription) (antiviral) [137]
DENV transmembrane signaling -PVR receptor tyrosine kinase (antiviral)-Pvf2 ligand of PVR (antiviral) [111]
Iridoviridae IIV-6 translation Pelo/Hbs1 complex (proviral) [135]
Nodaviridae FHV RNAi (siRNA, miRNA) Ars2 (antiviral) [124]
FHV glycerophospholipid metabolism Ace, Cct1, Cct2, fu12, and san (proviral) [130]
Rhabdoviridae VSV endocytosis Rab5 (proviral) [126]
VSV RNAi (siRNA, miRNA) Ars2, CBP20, CBP80 (antiviral) [124]
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Table 1. Cont.
Virus Family Virus Cellular Process Genes/Factors/Complexes References
VSV autophagy
-Atg5, Atg7, Atg8a, Atg12, Atg18
(autophagy machinery) (antiviral)
-Toll-7 (signaling pathway) (antiviral)
-Akt, PTEN (signaling pathway) (proviral)
[26,101]
VSV transcriptional pausing,induction of antiviral genes
-NELF (negative elongation factor (antiviral)
-P-TEFb (positive elongation factor) (antiviral) [118]
VSV induction of antiviral genes
-Nup98 (nucleoporin with role in transcription) (antiviral)
-FoxK transcription factor (antiviral)
-B52 (virus-induced gene) (antiviral)
[136,137]
VSV intracellular signaling ERK signaling pathway(dSos, dRas, dMek, dErk (rl), ksr, cnk) (antiviral) [113]
VSV transmembrane signaling -PVR receptor tyrosine kinase (antiviral)-Pvf2 ligand of PVR (antiviral) [112]
VSV chromatin remodeling TIP60 histone acetyltransferase complex (antiviral) [110]
VSV nucleo-cytoplasmic shuttling XPO1, aldolase (antiviral) [110]
VSV RNA degradation -3
′-to-5′ RNA exosome (dRrp6, dDis3, dRrp4, dRrp41) (antiviral)
-exosome cofactor TRAMP complex (dMtr4, dZcchc7) (antiviral) [115]
Togaviridae SINV RNAi (siRNA, miRNA) Ars2 (antiviral) [124]
SINV cellular receptor for virus entry dNRAMP (Mvl) (proviral) [117]
SINV ER-associated protein degradation(ERAD) pathway, proteasome dSEC61A, dVCP, dPSMD11 (proviral) [119]
SINV transcriptional pausinginduction of antiviral genes
-NELF (negative elongation factor (antiviral)
-P-TEFb (positive elongation factor) (antiviral) [118]
SINV induction of antiviral genes
-Nup98 (nucleoporin with role in transcription) (antiviral)
-FoxK transcription factor (antiviral)
-B52 (virus-induced gene) (antiviral)
[136,137]
SINV intracellular signaling ERK signaling pathway(dSos, dRas, dMek, dErk (rl), ksr, cnk) (antiviral) [113]
SINV transmembrane signaling -PVR receptor tyrosine kinase (antiviral)-Pvf2 ligand of PVR (antiviral) [112]
SINV RNA degradation -3
′-to-5′ RNA exosome (dRrp6, dDis3, dRrp4, dRrp41) (antiviral)
-exosome cofactor TRAMP complex (dMtr4, dZcchc7) (antiviral) [115]
SINV RNA degradation Drosha (RNAi independent) (antiviral) [122]
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3.2.3. Other Host Factors Required for Viral Infection (VSFs)
A common pathway for viruses to enter cells is endocytosis which is reflected by the sensitivity
of DCV and VSV to the knockdown of the small GTPase Rab5, a regulator of endosomal trafficking
(used as positive control in RNAi screens [126,134]).
A genome-wide RNAi screen using Drosophila cells also identified several classes of host factors
that are required for DENV infection (proviral genes), involved in processes such as endocytosis,
vesicular transport, vacuolar identification, ER function, unfolded protein response and RNA
metabolism (Table 1; [120]). It is not clear whether the identified VSFs are specifically required
for DENV (flavivirus) infection since no comparisons were carried out with other virus infections.
All viruses with a positive strand RNA genome are known to undergo replication in association
with membranes of the infected cells. Such targeted localization is thought to provide advantages such
as efficient separation of different viral functions (replication, transcription, translation) and protection
from immune recognition. The requirement to associate with cellular membranes was revealed during
a whole genome RNAi screen for identification of proviral genes during DCV infection [134]. More
specifically, the COPI coatamer complex, responsible for retrograde transport of recycled proteins from
Golgi to ER, and fatty acid metabolism (the enzyme fatty acid synthase and the master transcriptional
regulator of lipid homeostasis SREBP) were identified as limiting factors/processes during DCV
infection. However, whether infections of other insect RNA viruses and arboviruses were equally
sensitive as DCV to the identified genes/processes was not directly investigated.
At later stages of viral infection high amounts of structural (capsid) proteins are required
indicating the need for an efficient translation process. A limiting factor in this process could be the
occurrence of stalled ribosomes as a consequence of translation errors. The pelo/Hbs1 complex, which
recognizes and resolves stalled ribosomes as part of a quality control process of protein translation,
was identified as required for efficient replication of a diversity of viruses such as CrPV and DCV,
the birnavirus DXV and the DNA virus IIV-6 [135]. Initially identified as a VSF in a screen of a
collection of mutant Drosophila flies, the requirement was subsequently shown by RNAi knockdown in
S2 cells. The interference of pelo with viral replication did not occur through inhibition of RNAi or the
induction of the JAK/STAT pathway and Vago ([135]; see also below in Section 3.4).
3.2.4. Broad Range Antiviral Defense Programs
Arbovirus infection of Drosophila cells results in the induction of an antiviral program that
is transcriptionally complex and includes components of the immune pathways JAK/STAT, Imd,
Toll, RNAi and autophagy [118]. Part of the antiviral transcriptional program is affected by the
transcriptional pausing machinery (negative elongation factor NELF and positive elongation factor
P-TEFb; Table 1) which is responsible for a rapid response to virus infection. Increases in infectivity
following suppression of transcriptional pausing are observed for different arboviruses such as KUN,
RVFV, VSV and SINV, but also the Drosophila-specific virus DCV [118]. Further studies demonstrated
the involvement of the nucleoporin Nup98, that also can function in transcription, and the transcription
factor FoxK in the induction of the antiviral program [136,137], while also an antiviral function could
be demonstrated for some of the induced genes such as the splicing factor B52 which was analyzed in
more detail [137].
Targeted RNAi screens also identified the receptor tyrosine kinase PVR (Drosophila PDGF/VEGF
receptor) and the ERK pathway as a broad-acting antiviral defense mechanism (restricting DCV,
VSV, SINV and DENV; Table 1) [112,113]. Interestingly, in the intestinal epithelium this pathway is
dependent on the gut microbiota that act by priming the gene encoding Pvf2, a ligand for the PVR
receptor kinase, to be able to respond rapidly following viral infection through a mechanism that also
involves transcriptional pausing [112]. The antiviral immune mechanism in the gut epithelium is also
dependent on the Imd pathway and will be discussed in greater detail below.
Other broadly acting host factors that restrict arbovirus (two strains of WNV, DENV, SINV, RVFV
and VSV) infection in S2 cells and were subsequently validated in adult flies and mosquito cells,
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include the Tip60 histone acetyltransferase complex, involved in chromatin modeling, and dXPO1,
a karyopherin protein that exports proteins and RNAs from the nucleus to the cytoplasm (Table 1; [110]).
An antiviral role was also demonstrated for the enzyme aldolase, for which the nuclear transport of its
mRNA was shown to be dependent on dXPO1.
It is not surprising that also the (non-RNAi) RNA degradation machinery was identified as an
antiviral defense mechanism acting against arboviruses with both positive (SINV) and negative
strand (VSV, RVFV) ssRNA genomes [115]. Viral RNAs often have distinctive features such as
dsRNA structures, 5′-triphosphates and short or absent poly(A) tails and such “aberrant” RNAs
can be bound by RNA-binding cofactor complexes for subsequent targeting to the RNA degradation
machinery. In targeted RNAi screens both the 3′-to-5′ RNA exosome and components of the exosome
cofactor complex TRAMP (Trf4/5–Air1/2–Mtr4 polyadenylation) were implicated in antiviral defense
(Table 1; [115]). On the other hand, no factors of the other exosome cofactor complexes (Ski, NEXT)
were found to be involved, revealing some specificity in the viral RNA recognition process. In contrast,
as noted earlier, a 3′–5′ exonuclease and RNA-binding proteins were also identified as proviral during
RNAi screens of DENV flavivirus infections (Table 1; [120]). This difference may be caused by the
experimental set-up of the RNAi screens which can be biased to the identification of proviral genes
(sensitized at high infection rate) versus antiviral genes (sensitized at low infection rate) [110].
3.3. Involvement of Innate Antimicrobial Immune Pathways (Toll and Imd)
Innate immunity against bacterial and fungal infection classically is divided between humoral
and cellular immunity. Most cellular immune responses, such as phagocytosis, melanization and
encapsulation, are mediated by the hemocytes while secretion of AMPs following pathogen infection
is carried out by fat body tissue [138].
The Toll and Imd pathways are both NF-κB-related pathways that are activated by Gram-positive
bacteria/fungi or Gram-negative bacteria, respectively. In the case of the activation of the Toll pathway,
interaction of pathogen-associated molecular patterns (PAMPs) with pathogen recognition receptors
(PRRs) results in a proteolytic cascade leading to the processing of Spätzle. The Toll signaling pathway
is activated following the binding of Toll by Spätzle and culminates in the induction of AMP gene
expression by the NF-κB transcription factor Dif [27]. It is noted that a highly similar Toll pathway,
but with a different NF-κB transcription factor, Dorsal, acts to mediate dorsal-ventral patterning of
the early embryo [139]. Activation of the Imd pathway is also achieved after sensing PAMPs derived
from Gram-negative bacteria and results in the activation of the NF-κB transcription factor Relish
by a double-branched pathway, i.e., phosphorylation of Relish by the IκB kinase (IKK) complex and
cleavage of phosphorylated Relish by Dredd caspase [27].
Both Toll and Imd pathways have also been shown to be involved in antiviral innate immunity in
Drosophila. However, not all genes associated with bacterial or fungal infection seem to be functional,
indicating the existence of “non-canonical” Toll- and Imd-related pathways during antiviral defense.
Injection of DXV (Birnaviridae) in the hemocoel of adult flies results in the induction of AMP
genes that are associated with both Toll and Imd activation [140]. On the other hand, only particular
mutations in the Toll signaling pathway were shown to affect viral titers and virus-induced mortality.
Activation of the antimicrobial pathways may not be through direct recognition of viral PAMPs
but is suggested to occur indirectly through damage of infected tissues. Cellular debris released
during cell rupture could act as “damage-associated molecular patterns” (DAMPs) to activate the
antimicrobial signaling pathways [82,140–142]. AMPs do not protect directly against virus infection
since over-expression in transgenic flies does not confer protection against DXV [140]. Significant
induction of some AMP genes was also observed after Sigma virus (MelSV) infection [143].
In contrast to DXV and Sigma virus, injection of the dicistrovirus CrPV in Drosophila adult flies did
not result in an increase in AMP gene expression [144]. Weak or no AMP induction was also observed
during infection with DCV (Dicistroviridae; related to CrPV) [145,146]. On the other hand, mutations
in one of the branches of the Imd signaling pathway (dTAK1-kenny-Ird5; leading to phosphorylation
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of Relish), relish (rel) and the gene encoding peptidoglycan recognition protein-LC (PGRP-LC; a PRR
in the Imd pathway) resulted in increased sensitivity to CrPV infection. However, imd itself was
dispensable for the response against CrPV infection, as well as dFadd, acting in the second branch of
the canonical Imd pathway that leads to proteolytic cleavage of Relish. Thus, the different branches of
the Imd pathway may contribute differently to the antiviral response [144]. Virus-specific effects are
also apparent since relish mutations do not show a phenotype during DCV or DXV infections [140,147].
Furthermore, Dif (Toll pathway) and key (Imd pathway) did not have an impact on infectivity of DCV
after injection [98].
In flies that are transgenic for an inducible SINV replicon (inducible viral replication in the
absence of production of virions), both the JAK/STAT (see Section 3.4) and the Imd pathway (but
not the Toll pathway) were found to be implicated in antiviral resistance [148,149]. In this case, both
branches of the Imd pathway (Relish phosphorylation and cleavage) were shown to be involved
but not the (bacteria-specific) PRRs PGRP-LE and -LC. The induction of AMPs was also observed
and partly interpreted as a prophylactic immune response, aimed at the prevention of secondary
bacterial infections [148]. Interestingly, the direct involvement of the AMPs Attacin C and Diptericin B
(encoded by attC and dptB, respectively) in the control of SINV replicons and SINV viral titers was
also demonstrated [149]. Knockdown of dptB in SINV replicon flies induced mortality at the early
pupation stage [149]. While a role for Dicer-2 was identified to restrict SINV RNA replication by the
RNAi mechanism, the induction of Relish-mediated transcription was found to be independent of
Dicer-2 [148]. Thus, Dicer-2 does not function as a viral sensor in the activation of the Imd pathway,
in contrast to the JAK/STAT pathway ([147,150]; see Section 3.4). The antiviral action of the Imd
pathway (but not the Toll pathway) was also confirmed after injection of SINV virus in the hemocoel
and tissue-specific knockdown of Relish showed a major requirement for this NF-κB transcription
factor specifically in the hemocytes [148]. Induction of relish and the immune gene Thiol-ester containing
Protein II (TEPII) was also observed after SINV infection of S2 cells [118,151].
Previous studies mentioned in this section were carried out after the administration of the virus to
adult flies by injection, which is not a natural route of infection. Natural virus infections in Drosophila
occur by vertical transmission (Sigma virus or DMelSV) or by feeding (DCV, Nora virus). In the case of
DCV, however, differences in tissue tropism between the two methods of virus administration (injection
versus feeding) were only observed during the early stages when infection is more widespread after
injection than after feeding [96]. Nevertheless, the gut epithelial barrier must be considered as a
formidable obstacle against pathogen infection and it is expected that specific defense mechanisms are
associated with the gut epithelium. That route of infection can have a large impact on innate immunity
was demonstrated by the observation that mutations in the Toll pathway (Toll (Tl), spätzle (spz),
tube (tub) and pelle (pll)) result in increased susceptibility to oral but not systemic infection by DCV,
CrPV, Nora virus and FHV [96]. Interestingly, resistance to oral viral infection requires Dorsal as NF-κB
transcription factor and not Dif which is required to resist bacteria and fungi. The difference in viral
titers between wild-type flies and pll mutants is comparable with the difference observed for RNAi
mutants, underscoring the importance of the Toll pathway. However, also here the Toll pathway may
not be activated directly by the virus but secondarily through a secreted factor since activation of the
pathway (AMP reporter gene expression) can occur in cells not infected by the virus [96]. As already
suggested, tissue damage by viruses can also result in activation of the Toll pathway [142]. In such
case, activated Spätzle may act as a protective secreted factor (“cytokine”) to guard against the spread
of viral infections.
Interestingly, excessive activation of the Imd immune pathway can result in increased mortality
caused by viral infections. Such reduced viability was observed in diedel (die) mutants of Drosophila
after infection with SINV virus (but not with other RNA viruses such as VSV, DCV, CrPV and FHV) in
the absence of increases in viral titers [152]. Diedel is a small (12 kDa) secreted factor produced in the
fat body that is highly induced following SINV and VSV infection (while only SINV-induced mortality
is sensitive to die mutations). Induction involves a non-canonical Toll pathway that is dependent on
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the NF-κB factor Dif but not on the adaptor protein MyD88. Transcriptome analysis reveals increased
expression of immune-related genes in die mutants in the absence of infection that can be correlated
with reduced viability. During SINV infection, genes in the Imd pathway are much more strongly
induced in die mutants which was implicated in the pathological effects since the pathology phenotype
was rescued in double mutants of die and genes in the Imd pathway (key, imd) [152]. Diedel is therefore
considered an important regulatory point to “dampen” the immune response and to protect against
tissue damage. The necessity for tight control of immune pathways to prevent pathological damage
from excessive activation has also been reported for the JAK/STAT pathway and is related to the
concept of virus “tolerance” rather than “resistance” ([82,153,154]; see also Section 3.4).
As already mentioned in Section 3.2.4, RNAi screens identified a signaling circuit involving PVR,
its ligand Pvf2 and ERK signaling, that controls DCV and arbovirus (including SINV) infections [112].
When these studies were extended to the gut epithelium, it was observed that priming by the microbiota
was necessary for robust induction of Pvf2 in the intestinal epithelium following viral infection.
The mechanism of priming of the microbiota however requires components of the Imd pathway
(Imd, Tak1) and the NF-κB factor Relish, but not the Toll pathway [112], which seems in contrast to
the previously mentioned study [96]. Both studies also found different effects of antibiotics on the
antiviral defense mechanism (no effect: [96]; proviral effect: [112]). Further studies are necessary to
explain the different experimental outcomes and to clarify the roles of both Imd and Toll pathways in
antiviral defense.
Polydnaviruses (Polydnaviridae; [155]) constitute non-replicative viral particles that are produced
in the female reproductive organs of parasitoid hymenopteran wasps and co-injected with the eggs in
(mainly lepidopteran) insect hosts [156]. Also, Drosophila has functioned as a model to study parasitoid
wasp infection [157], and to clarify the role of polydnaviruses in the suppression of the immune
response, particularly with respect to the inhibition of NF-κB signaling by polydnaviral Ankyrin
(Vankyrin) proteins [158–160]. However, in this case, the major purpose for suppression of the immune
response is the survival of the parasitoid eggs and larvae and not the facilitation of viral replication.
However, replication-defective polydnaviruses have evolved strategies for preferential translation of
viral mRNAs in host cells [161]. Whether polydnaviruses encode genes that suppress RNAi has not
been reported.
3.4. JAK/STAT Pathway
The major components of the JAK/STAT pathway comprise three Unpaired (Upd1, Upd2, Upd3)
ligands, the cytokine receptor Domeless (Dome), the Janus Kinase Hopscotch (Hop) and the signal
transducer and activator of transcription Stat92E [27]. The pathway is typically activated in a paracrine
fashion by binding of the ligands to the Dome receptor. Production of the ligands occurs after
recognition of infection through PRRs and pathways that are largely unknown.
Injection of the Drosophila-specific virus DCV in adult flies resulted in transcriptional induction of
approximately 150 genes that have a distinct profile compared to bacterial or fungal infections [146].
One of the genes with a unique virus-specific induction profile, virus-induced RNA 1 (vir-1), that
encodes a small protein without clear structural motifs, was studied in more detail. Genetic analysis
shows that vir-1 induction by DCV is regulated by the JAK/STAT pathway and binding sites for
the STAT transcription factor were identified in the promoter of vir-1. Interestingly, vir-1 expression
occurs in tissues that are different from the major sites of DCV infection, indicating a secondary
response possibly initiated by a secreted factor (“cytokine”) produced by virus-infected tissues [146].
The function of vir-1 in the antiviral response remains unidentified since over-expression of vir-1 in
transgenic flies does not protect against viral infection. It is also noted that none of the genes of the
RNAi machinery were induced following DCV infection [146].
The role of the JAK/STAT pathway was confirmed in flies mutant for the JAK kinase Hopscotch,
that showed higher mortality and increased viral titers after DCV and CrPV dicistrovirus infection,
but not after infection with other RNA viruses (VSV, FHV, DXV, SINV) and the DNA virus IIV-6 [34].
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Thus, while the RNAi pathway is broadly effective against many virus infections, the JAK/STAT
pathway seems to be more restricted to dicistrovirus infections. Specific responses against viral
infections are also apparent in genome-wide microarray studies where different sets of genes are
induced by DCV, SINV and FHV infections [34]. However, as already mentioned in the previous
Section 3.3, using another approach, the Stat92E transcription factor was shown to restrict the SINV
replicon in transgenic flies [148]. A later study confirmed that a majority of genes that are upregulated
in flies with a SINV replicon, had STAT Relish-binding sites in their promoters and are regulated by
STAT and Relish [149].
In addition, Vago, a secreted protein of 160 amino-acids with a conserved single “von Willebrand
factor type C” (VWC) domain [150], was also induced by DCV and SINV (but not FHV) infection [147].
The antiviral effect of Vago is required in the fat body and evidence indicates that Vago is directly
induced by virus infection in that tissue (in contrast to vir-1). Induction of Vago expression was
independent of the three main immune signaling pathways (Toll, Imd, JAK-STAT) but required an
intact DExD/H-box helicase domain of Dicer-2 [147]. Thus, Dicer-2 may function as a viral sensor to
induce innate antiviral immune defense pathways, similar to the RIG-I-like receptor (RLR) helicases in
mammals, to which Dicer-2 is evolutionary related with respect to its DExD/H-box helicase domain.
The relationship between vir-1 and Vago remains unclear since vir-1 remains fully inducible by virus
infection in vago (as well as dcr-2) mutants. In mosquito cells, on the other hand, it was demonstrated
that mosquito Vago could activate the JAK/STAT pathway to induce vir-1 expression [150]. Up to
13 factors with a single VWC domain can be identified in the Drosophila genome and their role may not
be limited to antiviral defense but likely extends to nutritional control and environmental stress [162].
Whether the particular Vago protein that is induced by DCV and SINV infection in Drosophila has a
specific function in antiviral defense or may also be involved in the regulation of other stress-related
processes needs further experimental verification.
The genes that are induced by dicistrovirus infection in Drosophila also include the ligands for the
Dome receptor, i.e., Unpaired 2 and 3 (Upd2 and Upd3) [34]. The induction of Upd2 and Upd3 was
suggested to be an indirect response [35] since it is known to occur after tissue damage and released
cell debris, for instance after septic injury [163] but possibly also after viral infection. The observation
that vir-1 is not induced by inactivated virus or dsRNA but requires viral replication [164] is also
consistent with an indirect response to “danger signals” rather than direct activation of a pathway
through specific interaction between viral PAMP and host PRR [165].
A recent study indicated that over-expression of the JAK/STAT pathway can lead to increased
pathology and mortality during infection by RNA viruses (DCV, CrPV, DXV and FHV) but not by
a DNA virus (IIV-6) [153]. The epigenetic regulator and H3K9 methyltransferase G9a was found
to cause the “dampening” of the JAK/STAT-mediated antiviral response and therefore involved in
the mechanism of “tolerance” during RNA virus infection. In contrast to resistance, involved in the
control of viral titers, tolerance is associated with the limitation of damage that can occur during viral
infection [28,82,154]. Tight control of JAK/STAT signaling is necessary to achieve an efficient antiviral
immune response since both repression and over-stimulation can result in increased mortality [34,153].
As already discussed above (Section 3.3), negative control mechanisms were also reported to prevent
excessive activation of the Imd pathway and its possible associated immunopathology [152,166].
3.5. c-Jun N-terminal Kinase (JNK) Pathway
A strong transcriptional activation of the JNK pathway was also reported after intrathoracic
injection of DCV, which included pathway components (Hemipterous, Gadd45, Jra, Kay) as well as
downstream targets (Puckered and Rab-30) [153]. In addition, promoter regions of differentially
expressed genes were enriched for binding sites of the JNK signaling cascade transcription factor AP-1.
During RNAi screens in S2 cells, however, no association with the JNK pathway was found [113].
Inhibition of JNK signaling also did not impact viral infection in the intestine after feeding [112].
Viruses 2018, 10, 230 20 of 35
3.6. Transcriptional Programs Induced by Viral Infection
Analysis of microarray hybridizations and next-generation transcriptome sequencing has
revealed the complexity of the transcriptional programs of virus infections in cell lines or adult
flies. Transcriptional responses are considered to be virus-specific although this is obscured by
the poor reproducibility of transcriptome data [35]. Virus specificity of transcriptional responses is
probably also strongly affected by their different tissue tropism [28], in addition to type of genome or
replication strategy.
An overview of published transcriptome studies is presented in Table 2. Changes in gene
expression however do not reveal function and require additional experimentation to establish the
(negative or positive) role in the infection process. This can be achieved by RNAi-mediated silencing or
mutant analysis as discussed in many different examples in previous sections. This has resulted in the
identification of host factors necessary for viral infection (proviral genes) as well as the involvement
of the immune system such as the JAK/STAT pathway and RNAi (antiviral genes). From the large
number of genes that are altered upon viral infection (typically from about 100 to several hundred
in each transcriptome study) only for a low proportion their role in the infection process could be
confirmed, mainly because of the disproportionate effort to carry out the validation process.
Differential expression of genes is not necessarily a direct consequence of virus detection. Very
few viral sensors (PRRs) have been identified such as the helicase domain of Dcr-2 [147] and Toll-7 [26].
Virus infection often results in the generation of secondary transcriptional responses in other tissues
that are mediated by systemic signals [147]. Activation of the JAK/STAT pathway (vir-1, Turandot
proteins) likely is a secondary response caused by tissue damage and stress signals associated with
viral replication [35,153,167]. Unique responses can also be generated by pathological effects by the
virus, for instance during intestinal obstruction caused by DCV infection [168].
RNAi-related genes are usually not identified among the virus-induced genes [146]. This could
be related to the relative late time points of data collection post infection in most studies (Table 2) since
Dcr-2 was identified among the early genes (4 h post-infection (hpi)) induced after VSV infection in S2
cells [118].
As already indicated above, comparison of transcriptome data has also revealed their poor
reproducibility, even if infections were carried out with the same virus. As discussed by Marques
and Imler [31], this could be caused by (among others) differences in the experimental system
(cell lines versus adult flies) and infection routes (systemic versus oral), shortcomings of experimental
procedures (for instance, off-target effects in RNAi), heterogeneity in genetic background of Drosophila
strains, polymorphisms in host restriction factors and the unknown occurrence of persistent infections
(other viruses, Wolbachia). Infection by natural (Drosophila-specific viruses) and non-natural pathogens
(arboviruses) are expected to give different responses because of (absence of) co-evolution of the
pathogen with the host. Infections should be investigated in the right context because of the occurrence
of virus-specific and tissue-specific mechanisms.
3.7. Secreted Antiviral Factors and the Systemic Response
In mammals, the interferon system is a powerful system that is capable to restrict most viral
infections even in the absence of adaptive immunity [169,170]. Interferons are secreted factors that
are produced after detection of viral PAMPs (e.g., dsRNA) by PRRs (e.g., Toll-like receptor 3) [171].
Interferons subsequently stimulate the expression of antiviral interferon-stimulated genes through
activation of the JAK/STAT pathway [172]. Secreted factors and signals that induce a systemic response
are also produced during viral infections in Drosophila but how much such an “interferon-like” system
exists in invertebrates remains under debate [173]. Several secreted factors that play a role in the
regulation of the antiviral response in Drosophila were already discussed and include Vago (Section 3.4),
Pvf2 (Sections 3.2.4 and 3.3), Diedel (Section 3.3) and AMPs (Section 3.3). It is noted that the Unpaired
ligands of the JAK/STAT pathway are induced during dicistrovirus infections, possible through stress
signals and tissue damage [35], which can also be interpreted as the activation of a systemic antiviral
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response. Similarly, protease activity associated with necrosis or abnormal apoptosis of virus-infected
cells could activate the Spätzle ligand and induce the Toll pathway [96,142].
MALDI-TOF mass spectrometry was also used to analyze secreted factors in the hemolymph
following DCV infection which resulted in the identification of Pherokine-2 (Phk-2; [145]). Phk-2 is
related to a previously characterized odorant/pheromone-binding protein expressed in the antennae
and its developmental profile also suggests a role in tissue remodeling during metamorphosis.
Over-expression of Phk-2 in transgenic flies does not result in increased protection against DCV
infection [145].
3.8. Cellular Responses against Viral Infections: Phagocytosis, Apoptosis and Autophagy
Cell-mediated immunity in insects includes phagocytosis, nodulation, encapsulation and
melanization and is primarily mediated by the hemocytes or blood cells [174]. The majority of
blood cells constitute the macrophage-like plasmatocytes (90–95% of hemocytes in Drosophila) that are
specialized in the engulfment and degradation of cellular debris, debris and invading pathogens [175].
The involvement of cellular immunity in antiviral defense was dramatically demonstrated in
experiments of genetic ablation of hemocytes or inhibition of their phagocytotic capacity by injection
of polystyrene or latex beads [144,176]. Virus-specific effects were observed since cellular immunity
was required for resistance against CrPV, VSV and FHV but not against SINV or IIV-6. In the case of
DCV, phagocytosis was required to control infection at high doses [30] but was dispensable at low
doses [176]. During CrPV infection, hemocytes become depleted which is associated with the viral
dose and progression of infection [144].
The requirement for phagocytosis seems to be correlated with the induction of apoptosis during
viral infection. CrPV, DCV and FHV trigger apoptosis in the S2 cell line and apoptotic bodies can be
subsequently phagocytosed by plasmatocytes from adult flies [176] or l(2)mbn cells, a Drosophila
larval hemocyte-derived cell line [30]. In the latter study of DCV infection, it was shown that
phagocytosis preferentially targets apoptotic cells and that it involved the recognition of specific
features of apoptotic cells (e.g., exposed phosphatidylserine glycerophospholipid on the cell surface)
by the engulfment receptors Draper and integrin βν of the hemocytes [30]. Related to the importance
of apoptosis/phagocytosis to control DCV infections only at high doses, it was argued that other
defense mechanisms (e.g., RNAi) can reduce the levels of viral replication and damage to the point
where they are not pro-apoptotic (as seems to be the case for SINV). Nevertheless, the importance
of apoptosis to control viral infections was demonstrated by recombinant SINV viruses that express
the pro-apoptotic gene reaper [177]. Viruses expressing a pro-apoptotic gene were selected against to
establish persistent infections in mosquitoes, presumably because of the strong antiviral effect of the
pro-apoptotic gene [178].
In another study, injections of the RNA virus FHV or the DNA virus Autographa californica multiple
nucleopolyhedrosis virus (AcMNPV, Baculoviridae) in larval or adult Drosophila resulted in the rapid
(1–2 hpi) induction of pro-apoptotic “RHG” (reaper, hid, grim) genes, mainly in fat body tissue [179].
The early response in animals is in contrast to the late response in Drosophila-derived DL-1 cells in vitro
(24–36 hpi), where it is not associated with major effects on viral proliferation (see further below).
The rapid induction of RHG genes in fat body was followed by apoptosis at 2.5 hpi and resulted in
blockage of viral gene expression and proliferation. Genetic analysis indicated that induction was
dependent on the irradiation responsive enhancer region of the RHG gene cluster and the transcription
factor P53, as well as caspase (Dronc) activation [179]. It is noted that the induction of genes related to
apoptosis (e.g., caspase genes) was also observed in other transcriptome studies, e.g., [146].
The role of phagocytosis in antiviral defense against DCV infection was also investigated in
Drosophila cell lines S2 and DL-1. Knockdown of the GTPases Rab5 (early phagosome) and Ran (mostly
reported to be an essential player in nuclear transport but with additional role in phagocytosis) resulted
in lower levels of phagocytosis of DCV and was associated with higher viral titer [180]. Studies of
infection of S2 cells with white spot syndrome virus (WSSV, Nimaviridae, a shrimp DNA virus that does
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not replicate in Drosophila) showed engulfment but no degradation of WSSV indicating mechanisms
to avoid phagosome maturation and lysosome-mediated degradation [181]. Activation of the Toll or
Imd pathway by lipopolysaccharide or peptidoglycan was sufficient to target WSSV to the lysosomes.
Gene expression profiling followed by functional studies indicated a role for dally (division abnormally
delayed, encoding a cell surface receptor) and the associated Wnt signaling pathway in phagocytosis of
WSSV virus [181].
The mechanism of induction of apoptosis by viral infection was analyzed in greater detail in
DL-1 cells with respect to the RNA virus FHV and the DNA virus AcMNPV (to be discussed in the
paragraphs below). As mentioned earlier, virus-induced apoptosis in the cell line is a late event and is
not associated with protection against viral multiplication [182], in contrast to infections in animals.
It is speculated that the early mechanism of stress-induced cell death is lost during the selection process
for establishment of permanent cell lines which points to a limitation in the use of cell lines to study
mechanisms of antiviral defense [179].
In DL-1 cells, for both FHV and AcMNPV infections, apoptosis is induced following a depletion of
the cellular anti-apoptotic factor DIAP1 (Drosophila inhibitor-of-apoptosis 1) [182,183]. The reduction
of DIAP1 results in the activation of (initiator Dronc/Dark and effector Drice) caspase activity followed
by cytolysis and membrane blebbing, being hallmarks of apoptosis. General shutdown of cellular
protein synthesis is considered to contribute to DIAP1 depletion and the induction of apoptosis during
FHV infection [182].
While the baculovirus AcMNPV is mainly known to infect lepidopteran insects and cells, it can
also support DNA replication and induce apoptosis in DL-1 cells [184]. The use of DL-1 cells
and the extensive knowledge of apoptosis pathways in Drosophila have contributed significantly
to the understanding of the mechanism by which baculoviruses induce and simultaneously prevent
(by production of apoptosis inhibitors) the process of apoptosis. These pathways likely also apply
to infections of other DNA viruses that are specific to Drosophila but have not been studied yet.
In summary, the pathway is initiated following viral DNA replication in the nucleus which triggers
the DNA damage response and the activation of the phosphatidylinositol 3-kinase-like kinases ATM
and ATR. Phosphorylation of the histone 2A variant H2AX is considered crucial for the amplification
of the response and the recruitment of additional components in the pathway, including DNA repair
factors [185]. Typical cellular responses are cell cycle arrest to allow DNA repair, and apoptosis to
remove damaged cells. Upon activation of the DNA damage response, it can be speculated that the
transcription factor P53, which is involved in the DNA damage response and also a regulator of the
RHG gene cluster, can upregulate pro-apoptotic genes to destabilize DIAP1 which is central to the
initiation of apoptosis as mentioned above.
While a role for phagocytosis/apoptosis in antiviral defense has become evident recently,
less is clear about the involvement of another cellular process, autophagy. As already mentioned
(Section 3.2.2), RNAi screens have identified a role for autophagy and Toll-7 in the antiviral defense
against viruses with a negative strand RNA genome such as VSV and RVFV [26,101,129]. Another
study focused on the analysis of fly mutants of the autophagy gene Atg7 and confirmed a role for
autophagy in the control of VSV although the effects were considered mild [176]. By contrast, VSV
infection levels were not affected in Toll-7 mutants, in contrast to other studies [26,129]. No involvement
of autophagy was found for the positive strand RNA viruses SINV, DCV, CrPV and the DNA virus
IIV-6 while increased survival and decreased viral loads in Atg7 mutants were observed for FHV
(another positive strand RNA virus). FHV replication occurs at mitochondrial membranes and it is
speculated that the removal of damaged mitochondria through autophagy (“mitophagy”) contributes
to the success of FHV replication [176].
3.9. Heat-Shock Proteins and Stress
Transcriptome studies have revealed a role for the heat shock response in antiviral defense.
Infection of S2 cells or adult flies with DCV results in the induction of 6 genes encoding various
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heat-shock proteins (Hsp70Ab, Hsp70Ba, Hsp22, Hsp23, Hsp26, Hsp27) [167]. Additionally, CrPV
infections result in the induction of heat-shock protein genes but with delayed kinetics, while for a
IIV-6 a clear heat-shock response is observed in S2 cells but not in adult flies. Furthermore, flies mutant
for Heat shock transcription factor (Hsf ) or transgenic flies with fatty body-specific knockdown of Hsf
are more sensitive to viral infection [167]. The heat-shock response acts independently of RNAi or
Jak-STAT pathway since no interference with RNAi-mediated silencing or antiviral gene induction
is observed in Hsf mutants or knockdown animals. Finally, over-expression of Hsf or the heat-shock
protein Hsp70 increases viral resistance. One possible mechanism for heat-shock proteins in antiviral
defense could be their release from damaged cells and their subsequent action as “damage-activated
molecular patterns” (DAMPs) to activate immune cells (hemocytes) as is observed in mammals [186].
While induction of heat-shock proteins is a late response (48 hpi) to CrPV infection in adult
flies [167], studies in S2 cells have shown that CrPV inhibits the heat-shock response during early
infection [24] which could be related to the rapid shutdown of host mRNA translation [187]. Although
CrPV RNA and protein amounts are elevated at higher temperature, infectious virion production is
nevertheless reduced by an unknown mechanism.
During infection of S2 cells with dicistroviruses (DCV and CrPV), extensive modulation occurs
of stress granules and P-bodies, membrane-less organelles that contain RNA and protein complexes,
while other types of poly(A)+ RNA granules are induced [188]. Inhibition of stress granule
formation is considered important to keep viral RNA and proteins available for processing, translation
and replication.
Since heat-shock proteins are molecular chaperones that mediate protein folding and re-folding,
they are expected also to assist during specific molecular processes during viral infection. During FHV
infection, the heat-shock protein Hsp90 is required for efficient translation of the RNA-dependent RNA
polymerase (protein A) which becomes anchored in the external mitochondrial membrane during
translation [189,190].
A more intimate relationship may exist between the heat-shock response and the RNAi machinery
than expected. Besides their role in the cytoplasm during posttranscriptional gene silencing, the siRNA
pathway factors Dcr-2 and Ago-2 also have a role in the nucleus to control the processivity of
RNA polymerase II on euchromatic loci [191]. More specifically, knockdown of ago-2 or dcr-2
results in a significant increase in Hsp70 transcripts under non-heat shock conditions. Chromatin
immunoprecipitation and DNA fluorescence in situ hybridization experiments further demonstrate
that both Ago-2 and Dcr-2 are integrated in the regulatory complex that causes RNA polymerase II
pausing and play a role in the correct execution of the global transcriptional repression after heat-shock.
Consistent with a role for the siRNA pathway in stress regulation, it was reported that dcr-2 mutants
were more sensitive to different types of stresses such as toxic chemicals, starvation and cold shock,
and had a reduced lifespan [192]. Furthermore, abnormal lipid and carbohydrate metabolism was
associated with loss of Dcr-2 and comparative proteomics revealed changes in expression of proteins
associated with cellular metabolism, stress resistance, cell cycle [192].
During heat shock, Dcr-2 protein levels are reduced and dicing activity of long dsRNA substrates
is diminished [193]. Furthermore, heat shock results in fragmentation of tRNAs which compete with
canonical substrates of Dcr-2 such as long dsRNAs for processing. The RNA methyltransferase Dnmt2
was shown to be involved in the suppression of continuous tRNA fragmentation and consequently the
recovery of the siRNA pathway after heat shock [193]. Interestingly, Dnmt2 mutants show increased
infection by the RNA viruses DCV and Nora virus [194]. Conversely, over-expression of Dnmt2 caused
increased resistance to oral infection by DCV that was partly dependent on its methyltransferase
activity. In Dnmt2 mutants, the upregulation of immune response genes was muted. Binding of Dnmt2
to DCV RNA was also demonstrated and may contribute to virus control [194].
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3.10. Wolbachia Infection
Wolbachia is a maternally inherited bacterial endosymbiont that resides within membrane-bound
vacuoles of host cells and is widespread among arthropod species [138]. Wolbachia-infected flies are
more resistant against infection by the RNA viruses DCV, Nora virus and FHV, while no effect is
observed for infections with the DNA virus IIV-6 [195]. Protection by Wolbachia can occur very early
in the infection process, at the level of the initial translation of incoming RNA and early replicative
processes [52]. Furthermore, the antiviral resistance mechanism by Wolbachia occurs independent of the
activation of the innate Toll and Imd pathways [96,176] as well as both miRNA- and siRNA-mediated
RNAi [52]. Of interest is the observation that infections by Wolbachia can protect RNAi mutants (dcr-2,
ago-2, r2d2) against infection by DCV and FHV [196]. Antiviral resistance is considered a cellular
intrinsic mechanism that occurs in the absence of a transcriptional response in Wolbachia following viral
infection, and may occur for instance through competition for intracellular resources and space or by
remodeling the intracellular environment [52,197]. Wolbachia infections are also reported to stimulate
the production of reactive oxygen species (ROS) which could further provide antiviral protection
through stimulation of ERK signaling [198,199] (see also Sections 3.2.4 and 3.3 for the role of ERK
signaling). Protection by Wolbachia is variable, may depend on the Wolbachia strain and titer and can
occur by both tolerance and resistance mechanisms [67,197].
Table 2. Overview of transcriptome studies following viral infection in Drosophila adult flies or tissue
culture cells. The method used for genome-wide transcriptome analysis is also indicated (microarray,
RNAseq). Abbreviations: DCV, Drosophila C virus; DMelSV, Drosophila melanogaster Sigma virus; SINV,
Sindbis virus; FHV, Flock house virus; VSV, Vesicular stomatitis virus; WSSV, white spot syndrome virus;
CrPV, Cricket paralysis virus; SFV, Semliki forest virus; dpi, days post infection; hpi, hours post infection.
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4. Conclusions
Because of the wide range of genetic tools and online resources, the Drosophila model system has
enabled dramatic advances in many areas of biological research [201], including the immune response
against virus infections. Because research with Drosophila has acquired much more depth than with
other insects, it can function as a benchmark to inspire similar research in other insects. In this review,
information was gathered from the literature to evaluate the variety of defense mechanisms against
virus infections in Drosophila. The basic purpose of this investigation was to provide a comprehensive
overview of the multitude of antiviral defense strategies that include many non-RNAi pathways in
addition to RNAi.
RNAi seems to be involved as an antiviral response to a certain degree against most, if not all
virus infections. The importance of RNAi is most clearly illustrated by the specific generation of a
siRNA pathway in somatic tissues of insects that is dedicated to defense against invading nucleic
acids, and that is maintained separately from the miRNA pathway that regulates physiological and
developmental processes [12,15]. The requirement for base-pairing prior to initiation of degradation
provides great specificity and mechanisms for enhancement of efficiency have also evolved such as
amplification via DNA forms and production of secondary siRNAs followed by systemic spread via
exosomes [77,78]. On the other hand, efficiency of antiviral RNAi can be affected by physiological
conditions such as nutritional status and stress [21,167]. Furthermore, during persistent viral infections,
the RNAi pathway may be partially dismantled or may function in different ways that are not
completely understood [87].
Complementary to RNAi, many other antiviral mechanisms exist that are often virus-specific.
Viruses can trigger complex transcriptional responses during infection that overlap only in limited
extent with each other (Table 2). Many genes identified in such transcriptional responses remain to be
validated and for many factors it may also not be known whether they act provirally or antivirally.
Similarly, genome-wide RNAi screens have revealed many resistance mechanisms that occur in the
absence of RNAi (Table 1) [111]. Resistance against specific virus infections can readily occur by
mutation of proviral genes encoding “viral sensitivity factors”, i.e., cellular factors that are required for
efficient entry, replication and exit of a specific virus (Table 1). On the other hand, more broad antiviral
mechanisms also exist, such as those involving non-specific RNA degradation (Table 1). In Drosophila
populations, mutant flies can be identified that are resistant to viruses that naturally infect Drosophila
but not to viruses with broad host range usually not encountered in nature [94]. Analysis of the mutants
reveals antiviral defense mechanisms that are different from RNAi. Viruses also trigger apoptosis and
phagocytosis of apoptotic virus-infected cells is recognized as a broad antiviral strategy [30,176].
How virus infection is recognized is still a major issue since only a limited number of PRRs
recognizing viral PAMPs were identified such as the helicase domain of Dcr-2 and the Toll-7
receptor [26,147]. It is possible that virus infection is mainly detected in an indirect manner, for instance
through the damage incurred by encoded virulence factors or excessive viral replication [154]. Release
of cellular material such as proteases, heat-shock proteins and dsRNA subsequently may trigger
the activation of classical immune response pathways such as Toll, Imd and Jak-STAT. Priming of
these pathways may also function as prophylactic response against opportunistic bacterial or fungal
infections and invasion of microbiota from the gut.
A major question concerns whether the “alternative” antiviral defense pathways can provide
protection in the absence of RNAi. While not investigated systematically yet, it certainly seems possible
given the vast spectrum of antiviral defense mechanisms that already have been described. In the case
of Wolbachia infections, protection could be achieved in RNAi pathway mutants, indicating that RNAi
is not necessarily essential to control viral infection [196]. Clearance of low level Nora virus infections
and control of persistent infection could also occur in the absence of the RNAi machinery [202]. It is
therefore interesting to investigate more systematically the relative contribution of RNAi in the antiviral
response and whether RNAi efficiency is affected when other defense mechanisms predominate. While
Drosophila can function as a useful model, this issue is particularly important as it can be considered as
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a limiting factor in RNAi efficiency and interfere with the successful application of RNAi products in
the control of agricultural pests and vectors of diseases and the protection of beneficial insects from
parasite diseases. A good example is the successful application of dsRNA in the syrup to increase the
health of honeybee hives against dicistrovirus infections.
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